Back
Replimune Group Stock Predictions
Sell
22
REPL
Replimune Group
Last Price:
6.43
Seasonality Move:
4.2%
7 Day Trial
ALL ACCESS PASS
$
7
Replimune Group Stock Forecast
- Over the next 52 weeks, Replimune Group has on average historically risen by 4.3% based on the past 5 years of stock performance.
- Replimune Group has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Replimune Group Stock Undervalued?
The current Replimune Group [REPL] share price is $6.44. The Score for REPL is 22, which is 56% below its historic median score of 50, and infers higher risk than normal. - REPL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Replimune Group Stock Go Up Next Year?
- Over the next 52 weeks, Replimune Group has on average historically risen by 4.3% based on the past 5 years of stock performance.
Replimune Group Stock Rating
Sell
22
Replimune Group (REPL)
is a Sell
Is Replimune Group overpriced?
- Replimune Group has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Replimune Group Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
replimune.com
52-Week Data
52-Week High:
24.81
52-Week Low:
5.86
Prediction Charts
Market Cap:
395.51M
Price in USD:
6.44
Volume:
901.5K
Beta:
1.53
Technical Analysis
SMA50:
7.30
SMA100:
7.73
SMA200:
11.23
52-Wk Change:
-66.97%
Stock Predictions
-
Is Replimune Group stock public?
Yes, Replimune Group is a publicly traded company. -
What is the Replimune Group stock quote today?
The Replimune Group stock price is 6.44 USD today. -
How to buy Replimune Group stock online?
You can buy Replimune Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-30 | 6.49 | 6.35 | 6.62 | 6.35 |
May-1 | 6.36 | 6.46 | 6.76 | 6.22 |
May-2 | 6.54 | 6.57 | 6.66 | 6.37 |
May-3 | 6.80 | 6.95 | 7.08 | 6.61 |
May-6 | 7.22 | 7.01 | 7.24 | 6.93 |
May-7 | 7.04 | 6.89 | 7.27 | 6.83 |
May-8 | 6.78 | 6.68 | 6.83 | 6.57 |
May-9 | 6.65 | 6.76 | 6.79 | 6.51 |
May-10 | 6.76 | 6.41 | 6.95 | 6.38 |
May-13 | 6.46 | 6.59 | 6.84 | 6.34 |
May-14 | 6.64 | 6.71 | 7.01 | 6.54 |
May-15 | 6.92 | 6.81 | 6.96 | 6.72 |
May-16 | 6.64 | 6.72 | 6.76 | 6.27 |
May-17 | 6.79 | 6.44 | 6.93 | 6.41 |
Replimune Group Earnings
Replimune Group Earnings Report: Per Share Replimune Group Earnings Q1 Q2 Q3 and Q4 last year and next year.
Replimune Group Forecast Revenue Growth
Replimune Group Stock Analysis: Historical quarterly revenues per share for Replimune Group and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.35 per share, and a decrease next year of $0.01 per share.
* Replimune Group stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.